Clearstead Advisors’s Lumexa Imaging Holdings LMRI Stock Holding History

Clearstead Advisors’s Portfolio LMRI Stock Details LMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$68	Buy	+6	New	+$55	﹤0.01%	3428

Other funds holding LMRI

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

FMI

F/M Investments Washington, District of Columbia $1.97B AUM 30.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCA

Harbor Capital Advisors Chicago, Illinois $1.47B AUM 42.58% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Clearstead Advisors's LMRI Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Lumexa Imaging Holdings (LMRI) in Q2 2026: 6 shares worth $68. The stake represents ﹤0.01% of the portfolio and ranks #3428 among its holdings.

31 funds tracked by Wall St. Rank hold LMRI as of Q2 2026.

Clearstead Advisors held 6 shares of Lumexa Imaging Holdings worth $68 as of Q2 2026.
Lumexa Imaging Holdings was a new Clearstead Advisors position in Q2 2026.
Lumexa Imaging Holdings made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3428 holding.
31 funds tracked by Wall St. Rank held Lumexa Imaging Holdings as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.